Open AccessFORMULATION AND CHARACTERIZATION OF ODT USING DIFFERENT CO-PROCESS CONTAINING DACLATSVIR: IN VITRO AND IN VIVO PHARMACOKINETICS STUDY ON HEALTHY VOLUNTEERS FOR HEPATITIS C TREATMENT
Author(s) -
Dalia M N Abouhussein,
Mahmoud H. Teaima,
Adi Al-Nuseirat,
OSAMA BADARY,
Mohamed A. El-Nabarawi,
REHAB ABD EL-MONEM
Publication year - 2022
Publication title -
international journal of applied pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 15
ISSN - 0975-7058
DOI - 10.22159/ijap.2022v14i5.44289
Subject(s) - daclatasvir , in vivo , cmax , pharmacokinetics , friability , pharmacology , bioavailability , bioequivalence , in vitro , chemistry , medicine , hepatitis c virus , microbiology and biotechnology , biochemistry , biology , first pass effect , virology , virus , ribavirin